Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models - Dev, I K; Dornsife, R E; Hopper, T M (Br J Cancer, 2004)
et al.